Bliss GVS Pharma Limited
BLISSGVS
Rank in Stocks
#10143
Established in 1984 and headquartered in Mumbai, India, Bliss GVS Pharma... Established in 1984 and headquartered in Mumbai, India, Bliss GVS Pharma Limited specializes in the development, manufacturing, and distribution of a comprehensive array of pharmaceutical products. The company's pharmaceutical portfolio includes an extensive range of dosage forms, such as oral solids (tablets, capsules), various liquid and injectable preparations, topical applications (creams, gels), and advanced drug delivery systems like transdermal patches. Beyond conventional medicines, Bliss GVS also offers a diverse selection of other healthcare and personal care items, including balms, lotions, shampoos, and over-the-counter remedies. Their therapeutic focus is equally broad, encompassing solutions for anti-infectives, pain management, gastrointestinal issues, anti-malarials, dermatological conditions, nutritional support, and a wide variety of other wellness and hygiene products, including medicated and cosmetic soaps. The company actively engages in international exports, extending its market presence beyond India.
Share Price
$6.99
Last synced: 2026-11-11
Market Cap
$742.04M
Change (1 day)
0.25%
Change (1 year)
283.09%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bliss GVS Pharma Limited (BLISSGVS)
Category
Healthcare
Operating Margin for Bliss GVS Pharma Limited (BLISSGVS)
Operating Margin as of November 2026 TTM: 18.50%
According to Bliss GVS Pharma Limited's latest financial reports, its current operating margin (TTM) is 18.50%. At the end of 2025 the company had an operating margin of 35.07%.
Operating Margin history for Bliss GVS Pharma Limited from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 18.50% | -47.25% |
| 2025 | 35.07% | 118.23% |
| 2024 | 16.07% | 19.21% |
| 2023 | 13.48% | 4.66% |
| 2022 | 12.88% | -11.78% |
| 2021 | 14.60% | -10.43% |
| 2020 | 16.30% | -4.40% |
| 2019 | 17.05% | -41.75% |
| 2018 | 29.27% | 22.16% |
| 2017 | 23.96% | -24.37% |
| 2016 | 31.68% | 15.79% |
| 2015 | 27.36% | 51.24% |
| 2014 | 18.09% | -31.40% |
| 2013 | 26.37% | -15.72% |
| 2012 | 31.29% | 24.22% |
| 2011 | 25.19% | -10.99% |
| 2010 | 28.30% | -11.51% |
| 2009 | 31.98% | -10.57% |
| 2008 | 35.76% | 241.55% |
| 2007 | 10.47% | -65.12% |
| 2006 | 30.02% | 114.12% |
| 2005 | 14.02% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.69% | -98.94% |
DE
|
|
| 19.68% | -98.94% |
DE
|
|
| 13.26% | -99.28% |
JP
|
|
| 17.08% | -99.08% |
CH
|
|
| 10.53% | -99.43% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bliss GVS Pharma Limited's operating margin
What is Bliss GVS Pharma Limited's operating margin?
Bliss GVS Pharma Limited's operating margin is 18.50%, as of Nov 2026.
What was Bliss GVS Pharma Limited's operating margin in 2025?
In 2025, Bliss GVS Pharma Limited's operating margin was 35.07%, compared with 16.07% in 2024.
How has Bliss GVS Pharma Limited's operating margin changed since 2020?
From 2020 to 2025, Bliss GVS Pharma Limited's operating margin was highest in 2025 (35.07%) and lowest in 2022 (12.88%).
How does Bliss GVS Pharma Limited's operating margin compare with similar companies?
Bliss GVS Pharma Limited's operating margin (18.50%) is higher than that of 3 of the 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with 19.69%.